The plant seed oil extract easing mild joint pain

Pesky mild joint discomfort can make even the simplest tasks tricky. The good news? An alternative is now available to help relieve the mild aches and creaks.

Sure, age is just a number – it’s how we feel at heart that really matters.

Which is why no one wants to be slowed down by mild niggling aches and pains that can get in the way of living the way we would like.

Rather than just accept “that’s the way life is”, what if there was a way to relieve symptoms of mild osteoarthritis?

Enter Epiitalis® and yes, take a seat, we’re just about to explain exactly what that is.

What is Epiitalis®?

Funny word, we know, but this unique active ingredient comes with serious benefits.

Epiitalis® is a plant seed oil extract from the Biota orientalis tree.

It is composed of fatty acids and is patented for its anti-inflammatory effects and ability to help maintain healthy joint cartilage production.

Interested in Epiitalis®? Say hello to Epijoint®

Epijoint® is the brand name for the small, soft gel, flavourless liquid capsules now available at Chemist Warehouse, containing the ingredient we’ve just been talking about, Epiitalis®.

In clinical human research1, patients with symptoms of mild knee osteoarthritis taking a daily dose of Epiitalis® found that their mild joint pain decreased by approximately 50 per cent and their quality of life scores improved by over 80 per cent.

Not only that, clinical measures of mild joint pain and mild joint stiffness improved by around 50 per cent in patients taking a daily dose of Epiitalis®, compared to just 11.5 per cent in patents taking a placebo.

How often do I take Epijoint®?

Just take two capsules a day.

So, if you’re finding it harder than usual climbing the stairs, bending down to tie your shoelaces or getting out of bed in the morning, don’t lose hope.

Epijoint® is a new alternative that might just be the one you’ve been looking for.

Epijoint® opens a new door for sufferers by reducing and relieving the symptoms of mild osteoarthritis so that you can get back to moving how you feel.

* This article is brought to you by Epijoint. Always read the label and follow the directions for use.

1 Mitchell et al, 2022, Inflammopharmacology, 30(4), 1323-1334, retrieved March 2024 from This study was funded by Interpath Pty Ltd